Effects of three Chinese herbal therapies on gut microbiota and short-chain fatty acid metabolism in patients with mild, moderate, and severe ulcerative colitis: Multi-center, randomized, controlled trials
International Immunopharmacology · 2025
DOI: 10.1016/j.intimp.2025.114444 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Na Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Colitis, Ulcerative, Drugs, Chinese Herbal, Fatty Acids, Volatile. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 61 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Traditional Chinese medicines, as a burgeoning field of medication, significantly alleviate ulcerative colitis (UC) by improving intestinal microbiota-metabolism. Our previous studies demonstrated the significant efficacy of Hudi Enteric-coated capsules (HDEC), Qingchang Wenzhong decoction (QCWZ), and Modified Wumei pill (MWMP) using a mouse model of colitis. However, the mechanism of these therapies through the modulation of microbiota-metabolism remains uncertain. OBJECTIVE: Three multicenter randomized controlled trials were designed to explore the effects of three therapies on the microbiota-metabolism of UC patients with different severity. METHODS: A total of 143 patients with different severities of UC were recruited from 10 hospitals. The clinical efficacy of HDEC for mild UC, QCWZ for moderate UC, and MWMP for severe UC (SUCs) was evaluated by colorectal Mayo scores and systemic inflammatory indicators. The 16S rRNA sequencing and metabolomics were used to analyze intestinal microbiota and metabolite profiles. RESULTS: Three therapies used alone or combined with mesalazine (MS) were comparable to MS alone in improving Mayo scores and hematic inflammatory parameters. Microbial diversities and architectures of SUCs showed the greatest response to MWMP+MS than other medications, as reflected by the enriched Ruminococcus and Anaerostipes together with the reduced Enterococcus, Streptococcus, and Streptococcus anginosus. Furthermore, MWMP+MS boosted the production of the microbiota-derived short-chain fatty acids (SCFAs) of SUCs. These differential microbes and metabolites further displayed significant statistical relationships with clinical parameters. CONCLUSION: Herbal therapies, especially MWMP+MS, effectively improve microbiota composition and SCFA metabolism, which correlates with the improvements of serum inflammatory markers and endoscopic findings in patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
- Department of Gastroenterology, Dong Fang Hospital, Beijing University of Chinese Medicine, Beijing, China.
- Department of Gastroenterology, Dong Fang Hospital, Beijing University of Chinese Medicine, Beijing, China. Electronic address: junxiangli1226@126.com.
- Department of Immunology and Microbiology, School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China. Electronic address: penggy@bucm.edu.cn.
Zitieren
APA
Li, N., Shang, X., Shi, L., Li, Y., Mao, T., Wang, Q., Li, J., & Peng, G. (2025). Effects of three Chinese herbal therapies on gut microbiota and short-chain fatty acid metabolism in patients with mild, moderate, and severe ulcerative colitis: Multi-center, randomized, controlled trials. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114444
Vancouver
Li N, Shang X, Shi L, Li Y, Mao T, Wang Q, et al. Effects of three Chinese herbal therapies on gut microbiota and short-chain fatty acid metabolism in patients with mild, moderate, and severe ulcerative colitis: Multi-center, randomized, controlled trials. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114444
BibTeX
@article{Li2025,
author = {Li, Na and Shang, Xuekai and Shi, Lei and Li, Yalan and Mao, Tangyou and Wang, Qing and Li, Junxiang and Peng, Guiying},
title = {Effects of three Chinese herbal therapies on gut microbiota and short-chain fatty acid metabolism in patients with mild, moderate, and severe ulcerative colitis: Multi-center, randomized, controlled trials},
journal = {International Immunopharmacology},
year = {2025},
doi = {10.1016/j.intimp.2025.114444}
}
EUVIMED